Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China flag China · Delayed Price · Currency is CNY
16.42
-0.28 (-1.68%)
Sep 26, 2025, 3:04 PM CST

Shenzhen Kangtai Biological Products Company Description

Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China.

The company’s marketed vaccines include 13-valent pneumococcal polysaccharide conjugate vaccine, varicella vaccine, freeze-dried, hepatitis B vaccine, inflammatory vaccine, 23-valent pneumococcal polysaccharide vaccine, DTAP/HIB combined vaccine, diphtheria, tetanus and acellular pertussis combined vaccine, adsorbed, rabies vaccine (human diploid cell) for human use, hib conjugate vaccine, measles and rubella combined vaccine, sars-cov-2 vaccine, inactivated, and covid-19 vaccine.

Its research and development vaccines comprise measles, mumps and rubella vaccine, 2DTAP- HIB-IPV, 4-valent influenza (split), poliomyelitis vaccine (vero cells), and inactivated, sabin strain.

Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.

Shenzhen Kangtai Biological Products Co., Ltd.
CountryChina
Founded1992
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,913
CEOXiang Miao

Contact Details

Address:
Kangtai Group Building
Shenzhen, 518057
China
Phone86 755 26988558
Websitebiokangtai.com

Stock Details

Ticker Symbol300601
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100002Q33
SIC Code2836

Key Executives

NamePosition
Xiang MiaoPresident and Non-Independent Director
Jiankai LiuVice President and Non-Independent Director
Jin TaoVice President and Board Secretary